In patients with stable CAD, low plasma levels of PCSK9 were linked with a particular metabolic phenotype (low HDL-C, the metabolic syndrome, obesity, insulin resistance and DM) [19]. This evidence concerns the gene PCSK9 and metabolic syndrome.